Home > > > Report Detail

Global Gerd Drugs And Devices Market Forecast 2018-2026

Publisher Name :
Date: 19-Nov-2018
No. of pages: 140

KEY INSIGHTS

Gastro-esophageal reflux disease (GERD) is a chronic digestive disorder that occurs due to complications arising in the esophagus. The market is responsible for producing and distributing the drugs and devices required for its optimized cure and accurate diagnosis respectively. The global GERD drug and devices market has been predicted to grow at a CAGR of 1.12% between 2019 and 2027.

Market Insights

The causes primarily responsible for driving the GERD drug and devices market are the growing trend of self-medication for the increasing occurrence of GERD disorders and the prominence in awareness about GERD. Expiry of patents and the adverse effect of using proton pump inhibitors and other drugs for its cure are the majorly hampering the GERD Drug and devices market. The market is segmented by dosage form and by administration of the drugs.

Regional Insights

The global GERD Drug and devices market is spread over Europe, Asia-Pacific, North America, Latin America and the Middle East and Africa. The North American region has been proclaimed as the largest market for GERD drug and devices. The rise in the incidence of GERD in North American countries is responsible for the increase in demand for acid reducing and neutralizing drugs, which is proliferating the market growth in the North American region.

Competitive Insights

Product launch is a primary strategy adopted by the various market companies of the global GERD drug and devices market to gain a competitive edge. Some of the pioneering companies in this market are Abbott Laboratories, AstraZeneca, Ausch Health (Formerly Valeant Pharmaceuticals International, Inc.), Boston Scientific Corporation, Cempra Inc. (Merged with Melinta), Daewoong Co. Ltd., Eisai Inc., Glaxosmithkline, Ironwood Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co. Inc., Novartis, Pfizer, Inc., RaQualia Pharma Inc. and Takeda Pharmaceuticals Company Limited.

Global Gerd Drugs And Devices Market Forecast 2018-2026

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Antacids Drug Class Holds The Largest Market Share
3.2.2. Bravo System Devices Are Widely Used
4. Market Dynamics
4.1. Market Scope & Definition
4.2. Market Drivers
4.2.1. Growing Trend of Self-Medication
4.2.2. Increasing Awareness About Gerd
4.2.3. Increasing Occurrence of Gerd Disorders
4.2.4. Changes In Lifestyle
4.3. Market Restraints
4.3.1. Patent Expiry
4.3.2. Adverse Effect of Proton Pump Inhibitors And Other Drugs
4.3.3. Proton Pump Inhibitor Resistance
4.4. Market Opportunities
4.4.1. Increased Practice of Generics And Otc Drugs
4.4.2. Cost-Effective Otc Drugs
4.4.3. Overuse of Medication And Dietary Supplements
4.5. Market Challenges
4.5.1. Use of Complementary And Alternative Treatments
4.5.2. Probability of Buying Counterfeit Drugs
4.6. Market By Drugs Dosage Form
4.7. Market By Route of Administration of Drugs
5. Market By Drugs And Devices
5.1. Drug Class
5.1.1. Antacids
5.1.2. H2 Receptor Blockers
5.1.2.1. Cimetidine
5.1.2.2. Famotidine
5.1.2.3. Nizatidine
5.1.2.4. Ranitidine Hcl
5.1.3. Proton Pump Inhibitors (Ppi)
5.1.3.1. Nexium
5.1.3.2. Prilosec/ Losec
5.1.3.3. Aciphex/ Pariet
5.1.3.4. Dexilant
5.1.3.5. Protonix
5.1.3.6. Prevacid
5.1.3.7. Zegerid
5.1.3.8. Other Generic Ppi
5.1.4. Pro-Kinetic Agents
5.2. Devices
5.2.1. Digitrapper
5.2.2. Bravo System
5.2.3. Stretta
5.2.4. Linx Reflux Management System
5.2.5. Muse (Medigus Ultrasonic Surgical Endostapler) System
5.2.6. Other Devices
6. Key Analytics
6.1. Porter's Five Force Model
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitute
6.1.3. Bargaining Power of Suppliers
6.1.4. Bargaining Power of Buyers
6.1.5. Threat of Competitive Rivalry
6.2. Pipeline Drugs
6.3. Regulatory Framework
6.4. Patent Analysis
6.5. Opportunity Matrix
7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
7.2. Europe
7.2.1. The United Kingdom
7.2.2. Germany
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
7.3. Asia Pacific
7.3.1. Japan
7.3.2. China
7.3.3. India
7.3.4. Australia
7.3.5. South Korea
7.3.6. Rest of Asia Pacific
7.4. Rest of The World
7.4.1. Latin America
7.4.2. Middle East And Africa
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Company Profiles
8.2.1. Abbott Laboratories.
8.2.1.1. Company Overview
8.2.1.2. Product Portfolio
8.2.1.3. Scot Analysis
8.2.1.4. Strategic Initiatives
8.2.2. Astrazeneca
8.2.2.1. Company Overview
8.2.2.2. Product Portfolio
8.2.2.3. Scot Analysis
8.2.2.4. Strategic Initiatives
8.2.3. Bausch Health (Formerly Valeant Pharmaceuticals International, Inc.)
8.2.3.1. Company Overview
8.2.3.2. Product Portfolio
8.2.3.3. Scot Analysis
8.2.3.4. Strategic Initiatives
8.2.4. Boston Scientific Corporation
8.2.4.1. Company Overview
8.2.4.2. Product Portfolio
8.2.4.3. Scot Analysis
8.2.4.4. Strategic Initiatives
8.2.5. Cempra Inc. (Merged With Melinta)
8.2.5.1. Company Overview
8.2.5.2. Product Portfolio
8.2.5.3. Scot Analysis
8.2.5.4. Strategic Initiatives
8.2.6. Daewoong Co. Ltd.
8.2.6.1. Company Profiles
8.2.6.2. Product Portfolio
8.2.6.3. Strategic Initiatives
8.2.7. Eisai Inc
8.2.7.1. Company Overview
8.2.7.2. Product Portfolio
8.2.7.3. Scot Analysis
8.2.7.4. Strategic Initiatives
8.2.8. Glaxosmithkline
8.2.8.1. Company Overview
8.2.8.2. Product Portfolio
8.2.8.3. Scot Analysis
8.2.8.4. Strategic Initiatives
8.2.9. Ironwood Pharmaceuticals, Inc.
8.2.9.1. Company Overview
8.2.9.2. Product Portfolio
8.2.9.3. Scot Analysis
8.2.9.4. Strategic Initiatives
8.2.10. Johnson & Johnson
8.2.10.1. Company Overview
8.2.10.2. Product Portfolio
8.2.10.3. Scot Analysis
8.2.10.4. Strategic Initiatives
8.2.11. Merck & Co., Inc.
8.2.11.1. Company Profiles
8.2.11.2. Product Portfolio
8.2.11.3. Scot Analysis
8.2.11.4. Strategic Initiatives
8.2.12. Novartis
8.2.12.1. Company Overview
8.2.12.2. Product Portfolio
8.2.12.3. Scot Analysis
8.2.12.4. Strategic Initiatives
8.2.13. Pfizer, Inc.
8.2.13.1. Company Profiles
8.2.13.2. Product Portfolio
8.2.13.3. Scot Analysis
8.2.13.4. Strategic Initiatives
8.2.14. Raqual Ia Pharma Inc.
8.2.14.1. Company Overview
8.2.14.2. Product Portfolio
8.2.14.3. Strategic Initiatives
8.2.15. Takeda Pharmaceuticals Company Limited
8.2.15.1. Company Overview
8.2.15.2. Product Portfolio
8.2.15.3. Scot Analysis
8.2.15.4. Strategic Initiatives
List of Table
Table 1 Global Gerd Drugs And Devices Market By Region 2018-2026 ($ Million)
Table 2 Global Gerd Drugs And Devices Market By Drugs And Devices 2019-2027 ($ Million)
Table 3 Global Drug Class Market By Types 2019-2027 ($ Million)
Table 4 Global Drug Class Market By Region 2019-2027 ($ Million)
Table 5 Global Antacids Market By Region 2019-2027 ($ Million)
Table 6 Global H2 Receptor Blockers Market By Region 2019-2027 ($ Million)
Table 7 Global H2 Receptor Blockers Market By Types 2019-2027 ($ Million)
Table 8 Global Proton Pump Inhibitors (Ppi) Market By Region 2019-2027 ($ Million)
Table 9 Global Proton Pump Inhibitors (Ppi) Market By Types 2019-2027 ($ Million)
Table 10 Global Pro-Kinetic Agents Market By Region 2019-2027 ($ Million)
Table 11 Global Devices Market By Types 2019-2027 ($ Million)
Table 12 Global Devices Market By Region 2019-2027 ($ Million)
Table 13 Global Digitrapper Market By Region 2019-2027 ($ Million)
Table 14 Global Bravo System Market By Region 2019-2027 ($ Million)
Table 15 Global Stretta (Mederitherapeutics) Market By Region 2019-2027 ($ Million)
Table 16 Global Linx® Reflux Management System (Torax Medical) Market By Region 2019-2027 ($ Million)
Table 17 Global Muse™ (Medigus Ultrasonic Surgical Endostapler) System Market By Region 2019-2027 ($ Million)
Table 18 Global Other Devices Market By Region 2019-2027 ($ Million)
Table 19 Global Gerd Drugs And Devices Market By Region 2019-2027 ($ Million)
Table 20 North America Gerd Drugs And Devices Market By Country 2019-2027 ($ Million)
Table 21 Europe Gerd Drugs And Devices Market By Country 2019-2027 ($ Million)
Table 22 Asia Pacific Gerd Drugs And Devices Market By Country 2019-2027 ($ Million)
Table 23 Rest of The World Gerd Drugs And Devices Market By Country 2019-2027 ($ Million)

List of Figures

Figure 1 Global Gerd Drugs And Devices Market By Geography 2019-2027 ($ Million)
Figure 2 Global Gerd Drugs And Devices Market Share By Drugs And Devices 2017 & 2027 (%)
Figure 3 Global H2 Receptor Blockers Market By Cimetidine 2019-2027 ($ Million)
Figure 4 Global H2 Receptor Blockers Market By Famotidine 2019-2027 ($ Million)
Figure 5 Global H2 Receptor Blockers Market By Nizatidine 2019-2027 ($ Million)
Figure 6 Global H2 Receptor Blockers Market By Ranitidine Hcl 2019-2027 ($ Million)
Figure 7 Global Proton Pump Inhibitors (Ppi) Market By Nexium 2019-2027 ($ Million)
Figure 8 Global Proton Pump Inhibitors (Ppi) Market By Prilosec/ Losec 2019-2027 ($ Million)
Figure 9 Global Proton Pump Inhibitors (Ppi) Market By Aciphex/ Pariet 2019-2027 ($ Million)
Figure 10 Global Proton Pump Inhibitors (Ppi) Market By Dexilant 2019-2027 ($ Million)
Figure 11 Global Proton Pump Inhibitors (Ppi) Market By Protonix 2019-2027 ($ Million)
Figure 12 Global Proton Pump Inhibitors (Ppi) Market By Prevacid 2019-2027 ($ Million)
Figure 13 Global Proton Pump Inhibitors (Ppi) Market By Zegerid 2019-2027 ($ Million)
Figure 14 Global Proton Pump Inhibitors (Ppi) Market By Other Generic Ppi 2019-2027 ($ Million)
Figure 15 Porter's Five Force Model
Figure 16 Global Gerd Drugs And Devices Market Regional Outlook 2018 & 2027 (%)
Figure 17 The United States Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 18 Canada Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 19 The United Kingdom Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 20 Germany Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 21 France Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 22 Italy Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 23 Spain Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 24 Rest of Europe Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 25 Japan Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 26 China Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 27 India Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 28 Australia Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 29 South Korea Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 30 Rest of Asia Pacific Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 31 Latin America Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 32 Middle East And Africa Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 33 Gerd Ppis Drugs Provider Company Market Share 2017 (%)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs